Breaking News
Maud Sylvain-Neugart, Hoffmann Neopac, On Small Tubes for the Veterinarian Industry
In this video, Maud Sylvain-Neugart, Global Business Development Animal Health at Hoffmann Neopac AG, discusses the development of a new product line of small tubes for the veterinarian industry.
Sylvain-Neugart also emphasizes the importance of working closely with customers in the veterinarian industry to understand their needs and develop products that meet those needs. This customer-centric approach, combined with the company’s expertise in tube technology, has allowed them to create a successful new product line that has been well-received by the market.
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more
Katsuyuki Takeuchi, Terumo, on Medical Care Solutions
In this video, Katsuyuki Takeuchi, the Global Product Manager at Terumo Pharmaceutical Solutions, discusses the […]
Lena Wagner & Simone Marquardt, Raumedic, on Components for the Pharmaceutical and MedTech Industries
In this video, Lena Wagner and Simone Marquardt from Raumedic discuss the components that the […]
Sian Eden & Olivia Houselander, Owen Mumford, on Medical Devices
In this video, Sian Eden and Olivia Houselander from Owen Mumford, a medical device company, […]
Catherine Bianchi, Saint-Gobain, on Pharmaceutical Products
In the video, Catherine Bianchi, Marketing Group Leader of Bioprocess Solutions at Saint-Gobain, introduces the […]
Chris Philpott, Boddingtons, on Injection Molding
In this video, Chris Philpot, the Commercial and Technical Manager at Boddingtons, highlights the capabilities […]
Mario Franco Ruiz, H&T Presspart, on Innovation for Medical Devices
In the video, Mario Franco Ruiz, Sales Manager at H&T Presspart, discusses the company’s latest […]
Jared O’Connell, Honeywell, on Sustainability and Innovation
In this video, Jared O’Connell, the General Manager of Healthcare Packaging at Honeywell, discusses what […]
Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients
Eloxx Pharmaceuticals, a leader in ribosomal RNA-targeted genetic therapies for rare diseases, have announced the […]
Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS
Verge Genomics, a clinical-stage biotechnology company transforming drug discovery using artificial intelligence and human data, […]
DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board
DEM BioPharma, an immune-oncology company developing therapies that target signals on cancer cells and myeloid […]
Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera
Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today […]
Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic
Vyriad announces an expansion of a Phase 1 investigator-initiated trial at Mayo Clinic evaluating the […]
Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders
Astellas Pharma and Cullgen have announced a research collaboration and exclusive option agreement to discover […]
Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program
Auxilius Pharma has consolidated its funding of $1 Million for developing its lead asset, AUX-001, […]